Cargando…

PB1779: FLT3-ITD MUTATION CHARACTERIZATION WITH CLASSICAL PCR METHODOLOGY VERSUS CAPTURE- AND AMPLICON-BASED NGS PLATFORMS: A PETHEMA NGS-AML PROJECT

Detalles Bibliográficos
Autores principales:	Bilbao, Cristina, Stuckey, Ruth, Sargas, Claudia, Larráyoz, María J, Chillon, Maria Carmen, Diaz, Rosa Ayala, Carrillo, Estrella Cruz, Yébenes-Ramírez, Manuel, Martinez-Cuadron, David, Rodriguez-Veiga, Rebeca, Gil, Cristina, Bernal, Teresa, Burgues, Juan Miguel Bergua, Algarra, Lorenzo, Tormo, Mar, Sanchez, Maria Pilar Martinez, Saldise, Elena Soria, Serrano, Josefina, Dominguez, Juan Manuel Alonso, Boyero, Raimundo Garcia, Amigo, Maria Luz, Herrera-Puente, Pilar, Sayas, Maria J, Rubira, Esperanza Lavilla, Medina, Carlos Rodriguez, Sosa, Santiago Sánchez, Rodríguez-Afonso, Jorge, Reyes-González-Casanova, Paula, Rodríguez-Arbolí, Eduardo, Garcia, Joaquin Sanchez, Martinez-Lopez, Joaquín, García-Sanz, Ramón, Calasanz, Maria Jose, Barragan, Eva, Casares, Maria Teresa Gomez, Montesinos, Pau
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2023
Materias:	Publication Only
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430037/ http://dx.doi.org/10.1097/01.HS9.0000973972.93539.a0

Ejemplares similares

Networking for advanced molecular diagnosis in acute myeloid leukemia patients is possible: the PETHEMA NGS-AML project
por: Sargas, Claudia, et al.
Publicado: (2020)

Comparison of the 2022 and 2017 European LeukemiaNet risk classifications in a real-life cohort of the PETHEMA group
por: Sargas, Claudia, et al.
Publicado: (2023)

Molecular Landscape and Validation of New Genomic Classification in 2668 Adult AML Patients: Real Life Data from the PETHEMA Registry
por: Sargas, Claudia, et al.
Publicado: (2023)

Characteristics and Outcomes of Adult Patients in the PETHEMA Registry with Relapsed or Refractory FLT3-ITD Mutation-Positive Acute Myeloid Leukemia
por: Martínez-Cuadrón, David, et al.
Publicado: (2022)

No Evidence that CD33 rs12459419 Polymorphism Predicts Gemtuzumab Ozogamicin Response in Consolidation Treatment of Acute Myeloid Leukemia Patients: Experience of the PETHEMA Group
por: Castaño-Bonilla, Tamara, et al.
Publicado: (2022)

Treatment patterns and outcomes of 2310 patients with secondary acute myeloid leukemia: a PETHEMA registry study
por: Martínez-Cuadrón, David, et al.
Publicado: (2022)

Impact of FLT3–ITD Mutation Status and Its Ratio in a Cohort of 2901 Patients Undergoing Upfront Intensive Chemotherapy: A PETHEMA Registry Study
por: Ayala, Rosa, et al.
Publicado: (2022)

Azacitidine vs. Decitabine in Unfit Newly Diagnosed Acute Myeloid Leukemia Patients: Results from the PETHEMA Registry
por: Labrador, Jorge, et al.
Publicado: (2022)

Assessment of the clinical utility of four NGS panels in myeloid malignancies. Suggestions for NGS panel choice or design
por: Aguilera-Diaz, Almudena, et al.
Publicado: (2020)

Use of Venetoclax in Patients with Relapsed or Refractory Acute Myeloid Leukemia: The PETHEMA Registry Experience
por: Labrador, Jorge, et al.
Publicado: (2022)

Impact of Sars-Cov-2 Infection in Acute Myeloid Leukemia Patients: Experience of the Pethema Registry
por: Martínez, Pilar, et al.
Publicado: (2020)

PB1781: THE APPLICATION OF CF-DNA FOR NGS MRD STUDIES IN PATIENTS WITH LMA IMPROVES THE SENSITIVITY OF THE METHOD WITH RESPECT TO CTC.
por: Sánchez-Redondo, Noemí Álvarez, et al.
Publicado: (2023)

A pediatric regimen for adolescents and young adults with Philadelphia chromosome‐negative acute lymphoblastic leukemia: Results of the ALLRE08 PETHEMA trial
por: Ribera, Josep‐Maria, et al.
Publicado: (2020)

PLZF-RAR(α), NPM1-RAR(α), and Other Acute Promyelocytic Leukemia Variants: The PETHEMA Registry Experience and Systematic Literature Review
por: Sobas, Marta, et al.
Publicado: (2020)

The Mutational Landscape of Acute Myeloid Leukaemia Predicts Responses and Outcomes in Elderly Patients from the PETHEMA-FLUGAZA Phase 3 Clinical Trial
por: Ayala, Rosa, et al.
Publicado: (2021)

NGS-Based Molecular Karyotyping of Multiple Myeloma: Results from the GEM12 Clinical Trial
por: Rosa-Rosa, Juan Manuel, et al.
Publicado: (2022)

Comprehensive Custom NGS Panel Validation for the Improvement of the Stratification of B-Acute Lymphoblastic Leukemia Patients
por: Montaño, Adrián, et al.
Publicado: (2020)

Clinical outcomes after CPX‐351 in patients with high‐risk acute myeloid leukemia: A comparison with a matched cohort from the Spanish PETHEMA registry
por: Bernal, Teresa, et al.
Publicado: (2023)

A scoring system for AML patients aged 70 years or older, eligible for intensive chemotherapy: a study based on a large European data set using the DATAML, SAL, and PETHEMA registries
por: Bérard, Emilie, et al.
Publicado: (2022)

Prognostic significance of FLT3-ITD length in AML patients treated with intensive regimens
por: Castaño-Bonilla, Tamara, et al.
Publicado: (2021)

Bioinformatic Tools for NGS-Based Metagenomics to Improve the Clinical Diagnosis of Emerging, Re-Emerging and New Viruses
por: Ibañez-Lligoña, Marta, et al.
Publicado: (2023)

P498: INCIDENCE, RISK FACTORS AND OUTCOMES OF SECOND NEOPLASMS IN PATIENTS WITH ACUTE PROMYELOCYTIC LEUKEMIA: THE PETHEMA-PALG EXPERIENCE.
por: Sobas, Marta, et al.
Publicado: (2023)

Comprehensive NGS Panel Validation for the Identification of Actionable Alterations in Adult Solid Tumors
por: Martínez-Fernández, Paula, et al.
Publicado: (2021)

Impact of NGS in the medical sciences: Genetic syndromes with an increased risk of developing cancer as an example of the use of new technologies
por: Lapunzina, Pablo, et al.
Publicado: (2014)

P702: APPLICATION OF NEXT GENERATION SEQUENCING (NGS) FOR MINIMAL RESIDUAL DISEASE (MRD) AND CHIMERISM MONITORING IN MYELODYSPLASTIC SYNDROME (MDS) AFTER ALLOGENIC STEM CELL TRANSPLANTATION (ASCT)
por: Zamanillo, Irene, et al.
Publicado: (2023)

Improving the Management of Patients with Hearing Loss by the Implementation of an NGS Panel in Clinical Practice
por: García-García, Gema, et al.
Publicado: (2020)

Assessing Lysosomal Disorders in the NGS Era: Identification of Novel Rare Variants
por: Encarnação, Marisa, et al.
Publicado: (2020)

Optimized NGS Approach for Detection of Aneuploidies and Mosaicism in PGT-A and Imbalances in PGT-SR
por: García-Pascual, Carmen M., et al.
Publicado: (2020)

Helpful Criteria When Implementing NGS Panels in Childhood Lymphoblastic Leukemia
por: Vega-Garcia, Nerea, et al.
Publicado: (2020)

Editorial: NGS technologies of rare diseases diagnosis
por: Couce, María L., et al.
Publicado: (2022)

Comparison of next-generation sequencing (NGS) and next-generation flow (NGF) for minimal residual disease (MRD) assessment in multiple myeloma
por: Medina, Alejandro, et al.
Publicado: (2020)

NGS and phenotypic ontology-based approaches increase the diagnostic yield in syndromic retinal diseases
por: Perea-Romero, I., et al.
Publicado: (2021)

Identification of hereditary breast and ovarian cancer germline variants in Granada (Spain): NGS perspective
por: Molina-Zayas, María, et al.
Publicado: (2022)

Frequency, Clinical Characteristics and Outcome of Adult Patients with Acute Lymphoblastic Leukemia (ALL) and COVID-19 in Spain: Results of a Survey from Pethema and Geth Groups
por: Ribera, Josep-Maria, et al.
Publicado: (2020)

NGS-Based Analysis of Atypical Deep Penetrating Nevi
por: Manca, Antonella, et al.
Publicado: (2021)

K-seq, an affordable, reliable, and open Klenow NGS-based genotyping technology
por: Ziarsolo, Peio, et al.
Publicado: (2021)

NGS in Hereditary Ataxia: When Rare Becomes Frequent
por: Galatolo, Daniele, et al.
Publicado: (2021)

S130: PRELIMINARY RESULTS OF QUIWI: A DOUBLE BLINDED, RANDOMIZED CLINICAL TRIAL COMPARING STANDARD CHEMOTHERAPY PLUS QUIZARTINIB VERSUS PLACEBO IN ADULT PATIENTS WITH NEWLY DIAGNOSED FLT3-ITD WILD-TYPE AML
por: Montesinos, Pau, et al.
Publicado: (2023)

Novel Double Factor PGT strategy analyzing blastocyst stage embryos in a single NGS procedure
por: del Rey, Javier, et al.
Publicado: (2018)

SUMO-SIM Interactions Regulate the Activity of RGSZ2 Proteins
por: Garzón, Javier, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_jv83d3br685qlllpodpj56i9mh